Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Health Catalyst Adds World-Class Expertise in AI and Life Sciences

Appointments Mark a Major Step Toward Diversification Across Markets, and Leveraging AI to Derive Actionable Knowledge

Health Catalyst, Inc., a leader in next-generation data, analytics, and decision support, announced two important additions to its senior team—Jason Jones, PhD, and Elia Stupka, PhD.

Jason Jones will serve in a new role as Chief Data Scientist at Health Catalyst. Jones formerly held senior analytics leadership roles at Kaiser Permanente, recognized as one of America’s leading healthcare providers and not-for-profit health plans, as well as positions at Intermountain Healthcare, and Bayer Healthcare. Elia Stupka will serve as Health Catalyst’s Senior Vice President, Life Sciences Business, Chief Analytics Officer. Stupka comes to the company from Dana-Farber Cancer Institute, a Health Catalyst client, where he led data science and bioinformatics, and Boehringer Ingelheim Pharma, where he led computational biology.

“We are excited and deeply grateful that Jason and Elia joined us; with their skills and backgrounds, they could work anywhere,” said Dale Sanders, President of Technology for Health Catalyst. “As they both indicated during the lead-up to joining, they see Health Catalyst as being in a very unique position, poised for an impressive future. It’s one thing for me, with all my biases, to feel that way, but quite another for these two to feel the same and commit to joining the team when their career options were literally unlimited. They will take us to a new level of capability.”

Read More:  Ftc Seeks Expert Advice from Idx Ceo on Safely Introducing Real-World Ai

Elia Stupka is a visionary leader with a passion for innovation in health and life sciences and 20 years of experience across industry, academic and clinical settings. In his new role at Health Catalyst, Stupka is leveraging the company’s data to advance the life sciences—from drug discovery to understanding the patient impact of specific medications—as well as helping existing clients to build new research data ecosystems integrated with the existing operational ecosystems.

In his role at Dana-Farber Cancer Institute, one of the world’s leading cancer organizations, Stupka brought together research, clinical and operational data to improve patient outcomes and the discovery of new treatments. He started his career as a member of the first team to assemble the human genome in Cambridge, U.K., in 2001. He then worked with Nobel Laureate Sydney Brenner to build the first genome research group in Singapore.

Read More: AI is Revolutionizing Property Management to Make Your Job Easier

Related Posts
1 of 2,969

Subsequently, Stupka worked at several key European research organizations, including the Telethon Institute of Genetics in Naples, Italy; University College London; and Boehringer Ingelheim Pharma, where he was director of computational biology and genomics. He also co-directed a genomics research center at San Raffaele Hospital in Milan, Italy, where he contributed to the successful development and completion of the first commercially viable gene therapy clinical trials. He has published 100+ peer reviewed articles, cited 35,000+ times across the fields of bioinformatics, genomics, drug discovery, and ethics. His work has contributed to the understanding of the human genome and transcriptome, the diagnosis of rare disease patients, the development of gene therapy and novel drugs on the market and the development of ethics frameworks pertaining to the fast-changing world of big data in health and biology.

Jason Jones is passionate about achieving the Quadruple Aim through better and easier use of data in healthcare, including helping organizations to find analytic focus; helping providers feel that the systems they work for have their backs; and helping people to understand and have their goals and preferences respected for the hopefully brief periods during which they are “patients.”   He sees Health Catalyst as a unique organization in which to bring this passion to life.

Read More: Interview with Joe Edwards, Executive Director, Tonic3 & W3

“Interest in health and healthcare-related analytics has increased dramatically over the last decade, but few organizations have shown the focus on fundamentals and commitment to each client’s success as Health Catalyst over that time period,” said Jones.

Previously, Jones served as Vice President, Information Support for Care Transformation, at Kaiser Permanente (KP). In that capacity, he brought together and co-led the national Hospital and Healthplan Quality and Finance analytic functions and led development of national quality strategy and care delivery IT investments.  Prior to that, he was KP’s Executive Director of Clinical Intelligence and Decision Support and a Research Scientist in KP’s Southern Californiaregion.

Before joining KP, Jones was a Senior Medical Informaticist for Intermountain Healthcare. He also held analytic and marketing positions at Bayer Healthcare in Wayne, N.J., and Ingenix (now Optum) Pharmaceutical Information Products in Salt Lake City, where he developed a model for converting United Healthcare data into a saleable asset for external customers conducting outcomes research.

Throughout his career, Jones has taught graduate courses in statistics to medical informaticists at the University of Southern California and at the University of Utah. He has published dozens of peer-reviewed papers in medicine, predictive modeling, and outcomes improvement.

Read More:    Sarah Davies, Former VantageScore Executive, Joins Nova Credit

Leave A Reply

Your email address will not be published.